manidharma biotech private limited
Tender Performance & Track Record
Company Overview
Tender Performance
Data for 01 April 2024 to 17 June 2025
Total Bids / Contract Value
Qualified Bids / Q Rate
Total Wins / Win Value
Wins Rate / Q-W Rate
Detailed Performance Analysis
Top Bid Competitors
Companies that frequently compete with you in the same tenders — ranked by their total win value.You applied for 12 bids — SHREE SARASWATI SHAIKSHNIK SAHITYA KENDRA appeared in 4 of them.
MANIDHARMA BIOTECH PRIVATE LIMITED
MANIDHARMA BIOTECH PRIVATE LIMITED
Financial Details
Registered Office
PLOT NO-61, KAMATCHI NAGAR, KUNDRATHUR ROAD MADHANANDAPURAM, PORURNA-CHENNAI-Tamil Nadu-600116-India
Industry Classification
Manufacturing (Others)
Company Type
Market Information
Transform Your Tender Process
Join thousands of businesses winning more tenders
Smart Alerts
Get AI-powered tender recommendations
Market Intel
Track competitor bidding patterns
Email Reports
Weekly detailed analytics reports
Download Hub
Export tender data in bulk format
Smart Tracking
Never miss important deadlines
& Much More...
Discover all premium features with your trial
"TenderAI transformed our bidding process. We've increased our win rate by 40% and saved countless hours."
Historical Performance
7-year trend analysis (2018-2025)
Company Overview (1 Apr 2018-31 Mar 2025))
Total Bids
23
Contract Value
₹1.58 Cr
L1 Bids
6
Recent Win Rate
18.2%
Performance Analytics
Manidharma Biotech Private Limited: Comprehensive Government Tender Analysis
Manidharma Biotech Private Limited has actively participated in the Indian government tender landscape, submitting bids for 23 government tenders between April 2018 and March 2025. This analysis, powered by TenderAI, delves into their tender performance, providing insights into their qualification rates, competitive positioning, financial performance, and strategic opportunities within the public sector procurement ecosystem. Their 26.1% win rate and ability to secure 6 L1 positions demonstrate a reliable track record in government procurement.
With a successful conversion of bid value to won contracts, securing ₹1,57,73,869.0 in government contract value from April 2018 to March 2025, Manidharma Biotech's average Earnest Money Deposit (EMD) of ₹30,000.0 indicates their capacity to engage in substantial government tenders requiring significant bid security. Their tender history reveals engagement with key departments such as Department Of Agriculture Cooperation And Farmers Welfare, Forests And Environment Department Gujarat, and Agriculture Department Andaman & Nicobar, showcasing specific procurement expertise.
Technical qualification was achieved in 15 out of 23 tenders, with a qualification rate of 65.2%. This showcases their ability to satisfy technical criteria and compliance requirements. However, a disqualification rate of 34.8% highlights areas for improvement in documentation and specification adherence.
Overall, Manidharma Biotech's tender performance data provides valuable insights into their public sector capabilities, competitive advantages, and potential for future government contract success. This comprehensive analysis serves as a resource for evaluating their suitability as a procurement partner in India's diverse government tender ecosystem.
Financial Performance Analysis
Yearly Trends
Manidharma Biotech's financial performance in government tenders shows varying trends over the fiscal years. From FY2018-19 to FY2021-22, the company did not participate in any tenders. However, in FY2022-23, they participated in one tender with a total contract value of ₹12,44,991.0. The subsequent year, FY2023-24, saw a significant increase in activity with 11 bids and a total contract value of ₹1,14,00,953.0. However, FY2024-25 shows a decrease in contract value to ₹31,27,925.0 with 11 bids.